Stanford School of Medicine
Stanford, California, 94305, United States
NCT Number: NCT01716169
The purpose of this study is to test the effectiveness of Helicoll (a collagen wound dressing) in treating chronic and non-chronic wounds of recessive dystrophic epidermolysis bullosa (RDEB) patients. Helicoll will be compared to standard wound dressings.
Looking for future studies?
Notify Me7 year and older
All sexes
Interventional
Not applicable
Stanford, California, 94305, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All wounds must be:
Exclusion criteria
Helicoll Collagen I Wound Dressing
Standard of Care wound dressings (e.g. Vaseline gauze)
Time frame: Baseline and Week 8
Change was assessed in terms of wound surface area, as measured using the ARANZ camera. Week 8 surface area measurement was compared to baseline surface area measurement and percentage in size change was calculated.
Stanford University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01263379
Collagen Diseases, Congenital Abnormalities
Redwood City, California, United States
View Trial DetailsNCT07596927
Collagen Diseases, Congenital Abnormalities
São Luís, Maranhão, Brazil
View Trial DetailsNCT05843994
Carcinoma, Carcinoma, Squamous Cell
Chicago, Illinois, United States
View Trial DetailsNCT03786237
Carcinoma, Carcinoma, Squamous Cell
Salzburg, State of Salzburg, Austria
View Trial Details